Brochure
26 Aug 2024

Cerbios FDF based on probiotic strain SF68

PDF 689 kB
Download

Cerbios own and manufactures the strain Enterococcus lactis SF68 applied in different therapeutic areas:

- Diarrhea, travellers diarrhea and dysbiosis: drug with 20 clinical trials, CTD dossier and registration from Switzerland (for extra EU Countries)


- Acne & Seborrheic dermatitis
- Obesity/Cholesterol and metabiolic syndrome
- IBS
- Immunity Booster


Any product is supported by precilical and clinical evidences.


Cerbios business model if B2B, searching for commercial Licensees worldwide





Content provided by our supplier

Cerbios-Pharma SA

  • CH
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Custom Manufacturing/Custom Synthesis
Generic APIs producer
View company profile

Other Content from Cerbios-Pharma SA ()